Biotech startups that raised Series B in Hangzhou, China
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Qihan Biotech | Hangzhou | Series B | $16.0M | 2023-09-15 |
| Aorui Bio | Hangzhou | Series B | $13.7M | 2023-09-11 |
2 rows of the CSV in 5 of its 18 columns.
- The 23 biotech startups in Hangzhou, China whose last round is Series B have raised $316.2M in total.
- 2 of them closed their most recent round in the last 12 months, $43.7M combined.
- The largest of those rounds is Imbioray's $28.8M Series B, dated February 2026.
- The most recent is Qiantang Longyue's $14.9M Series B on 17 September 2026.
- Health care is the most common other sector, with 18 companies (78%).
- 22% were founded in 2020 or later; the median founding year is 2017.
- The most common team size is 11 to 50 employees (50% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
1 of 23| Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|
| Qihan Biotech | Qihan Biotech develops gene-editing technology for organ transplantation. | Biotech | Series B | $16.0M | 2023-09-15 | $116.3M | Matrix Partners China, Northern Light Venture Capital, CMB International Capital Corporation +1 | 101 to 250 | 2017 |
Table 1. Biotech startups that raised Series B in Hangzhou, China: the 1 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 23.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | Hongda Capital | Venture capital firm | Shanghai, China | 1 | 4% | ||
| 2 | Lucky Source Funds | Private equity firm | Shenzhen, China | 1 | 4% | ||
| 3 | LYFE Capital | Venture capital firm | Singapore | 1 | 4% | ||
| 4 | Source Code Capital | Venture capital firm | Chaoyang, China | 1 | 4% | ||
| 5 | Prox Ventures | Venture capital firm | Shanghai, China | 1 | 4% | ||
| 6 | Huagai Capital | Private equity firm | Beijing, China | 1 | 4% | ||
| 7 | ZSCO | Private equity firm | Hangzhou, China | 1 | 4% | ||
| 8 | Capitech | Venture capital firm | Xian Shi, China | 1 | 4% | ||
| 9 | Zhengxin Capital | Private equity firm | Haidian, China | 1 | 4% | ||
| 10 | Shenzhen Capital Group | Venture capital firm | Nanshan, China | 1 | 4% | ||
| 11 | Yinxinggu Capital | Venture capital firm | Hangzhou, China | 1 | 4% | ||
| 12 | Delta Capital | Venture capital firm | Shanghai, China | 1 | 4% | ||
| 13 | SooChow Securities | Investment bank | Suzhou, China | 1 | 4% | ||
| 14 | Sinowisdom | Venture capital firm | Hangzhou, China | 1 | 4% | ||
| 15 | Matrix Partners China | Venture capital firm | Beijing, China | 1 | 4% |
Table 2. Biotech startups that raised Series B in Hangzhou, China: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Health care | 18 | 78% | $316.2M |
| Artificial intelligence | 1 | 4% | |
| Hardware | 1 | 4% |
Table 3. Biotech startups that raised Series B in Hangzhou, China by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
| Funding stage | Companies | Share | Median last round |
|---|---|---|---|
| Series B | 23 | 100% | $16.0M |
Table 4. Biotech startups that raised Series B in Hangzhou, China by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| September 2026 | 1 | 50% | $14.9M |
| February 2026 | 1 | 50% | $28.8M |
Table 5. Biotech startups that raised Series B in Hangzhou, China: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 2 | 9% | $43.7M |
| 2025 | 3 | 13% | $42.1M |
| 2024 | 1 | 4% | |
| 2023 | 8 | 35% | $44.5M |
| 2022 | 3 | 13% | $14.3M |
| 2021 | 3 | 13% | $201.0M |
Table 6. Biotech startups that raised Series B in Hangzhou, China by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2020 to 2022 | 5 | 22% |
| 2015 to 2019 | 10 | 43% |
| 2010 to 2014 | 6 | 26% |
| Before 2010 | 2 | 9% |
Table 7. Biotech startups that raised Series B in Hangzhou, China by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 3 | 15% |
| 11 to 50 | 10 | 50% |
| 51 to 100 | 2 | 10% |
| 101 to 250 | 4 | 20% |
| 501 to 1,000 | 1 | 5% |
Table 8. Biotech startups that raised Series B in Hangzhou, China by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Biotech is one of its sectors and its most recent funding round is Series B and its headquarters is in Hangzhou, China. On 16 November 2026 that is 23 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 1 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 23 rows: 9 have no round amount, 0 no city and 8 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many biotech startups in Hangzhou, China whose last round is Series B are on the list?
- 23, in the file dated 16 November 2026. 2 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 23 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 2 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.